Frequency of Asbestos Exposure and Histological Subtype of Ovarian Carcinoma.
asbestos
environmental exposure
family exposure
occupational exposure
ovarian cancer
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
28 04 2022
28 04 2022
Historique:
received:
25
03
2022
revised:
21
04
2022
accepted:
26
04
2022
entrez:
14
5
2022
pubmed:
15
5
2022
medline:
20
5
2022
Statut:
epublish
Résumé
The International Agency for Research on Cancer established a causal link between asbestos exposure and ovarian cancer. However, the exposure frequency and histological characteristics of asbestos-associated ovarian cancers remain to be investigated in detail. This multicenter case-case study assessed the asbestos exposure in ovarian carcinoma (OC) patients, alongside its association with histological subtype. Women were recruited in four hospitals in Lyon, France. Histological reports were reviewed by a pathologist. Patient and family members' data were collected by phone-based questionnaires. Asbestos exposure was defined as direct (occupational and environmental) and indirect (via parents, partners, and children). An industrial hygienist assessed the probability and level of exposure. The 254 enrolled patients (mean age 60 years) reported having an average of 2.3 different jobs (mean working duration 29 years). The prevalence of direct and indirect asbestos exposure was 13% (mean exposure duration 11 years) and 46%, respectively. High-grade serous carcinoma accounted for 73% of all OCs and 82% of histological subtypes in women with direct exposure. After adjustment on a familial history of OC, no significant associations between asbestos exposure (direct and/or indirect) and high-grade serous carcinoma were found. Women with OC had a high prevalence of asbestos exposure. Establishing risk profiles, as reported here, is important in facilitating compensation for asbestos-related OCs and for the surveillance of women at risk.
Identifiants
pubmed: 35564776
pii: ijerph19095383
doi: 10.3390/ijerph19095383
pmc: PMC9100164
pii:
doi:
Substances chimiques
Asbestos
1332-21-4
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Cancer Causes Control. 2012 Jun;23(6):919-27
pubmed: 22527170
Ann Occup Hyg. 2011 Oct;55(8):865-78
pubmed: 21926066
Best Pract Res Clin Obstet Gynaecol. 2017 May;41:31-48
pubmed: 28254144
Menopause. 2016 Apr;23(4):417-24
pubmed: 26506499
J Clin Med. 2021 Jul 15;10(14):
pubmed: 34300298
Lancet. 2008 Jan 26;371(9609):303-14
pubmed: 18294997
Eur J Cancer Prev. 2017 Jan;26(1):55-62
pubmed: 26731563
Cochrane Database Syst Rev. 2019 Jun 18;6:CD008215
pubmed: 31207666
Int J Hyg Environ Health. 2019 Jan;222(1):22-29
pubmed: 30174219
Environ Health Perspect. 2011 Sep;119(9):1211-7
pubmed: 21642044
Lancet Oncol. 2012 Sep;13(9):946-56
pubmed: 22863523
J Natl Cancer Inst. 1999 Sep 1;91(17):1459-67
pubmed: 10469746
Diagn Cytopathol. 2013 Jul;41(7):654-7
pubmed: 22351650
Crit Rev Oncol Hematol. 2014 May;90(2):99-134
pubmed: 24387944
Am J Ind Med. 2013 Nov;56(11):1307-16
pubmed: 23939988
Occup Environ Med. 2007 Aug;64(8):500-1
pubmed: 17634249
Occup Environ Med. 2013 Dec;70(12):884-91
pubmed: 24142972
Arch Gynecol Obstet. 2013 Jun;287(6):1187-204
pubmed: 23503972
Lancet Oncol. 2011 Sep;12(9):900-4
pubmed: 21835693
Environ Health Perspect. 2007 Oct;115(10):1401-5
pubmed: 17938727
Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1287-95
pubmed: 21610219
Occup Environ Med. 2016 Jan;73(1):28-33
pubmed: 26403532
Am J Ind Med. 1997 Mar;31(3):280-6
pubmed: 9055950
Eur Respir J. 2009 Jul;34(1):72-9
pubmed: 19129281
Am J Ind Med. 2005 May;47(5):458-62
pubmed: 15828068
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
J Occup Environ Med. 2020 Feb;62(2):e65-e77
pubmed: 31868762
Int J Environ Res Public Health. 2016 Nov 14;13(11):
pubmed: 27854255
Cancer Causes Control. 2013 Jul;24(7):1459-64
pubmed: 23615817
Am J Ind Med. 1996 May;29(5):435-9
pubmed: 8732916
CA Cancer J Clin. 2018 Jul;68(4):284-296
pubmed: 29809280
J Cancer Epidemiol. 2015;2015:879302
pubmed: 26425123
Cancer Sci. 2013 Feb;104(2):245-9
pubmed: 23121131
Am J Respir Cell Mol Biol. 2010 Feb;42(2):133-9
pubmed: 20068227
Int J Gen Med. 2008 Nov 30;1:15-20
pubmed: 20428401
Int J Gynecol Cancer. 2021 Jan;31(1):122-128
pubmed: 33037108
Front Public Health. 2021 Sep 17;9:619581
pubmed: 34604147
Lancet Oncol. 2009 May;10(5):453-4
pubmed: 19418618
IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt C):11-465
pubmed: 23189751
Geburtshilfe Frauenheilkd. 2021 May;81(5):555-561
pubmed: 34035550